Stem cell platforms for regenerative medicine

Clinical and Translational Science

Volumn 2, Issue 3, 2009, Pages 222-227

  Nelson, Timothy J ^a   Behfar, Atta ^a   Yamada, Satsuki ^a   Martinez Fernandez, Almudena ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adult; Allogeneic; Autologous; Bioengineered; Embryonic; Immune response; Perinatal

Indexed keywords

ALKALINE PHOSPHATASE; E1A PROTEIN; FIBROBLAST GROWTH FACTOR 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN;

ADULT STEM CELL; BIOENGINEERING; BLASTOCYST; CELL DIFFERENTIATION; CELL GROWTH; CELL RENEWAL; CELLULAR IMMUNITY; DEGENERATIVE DISEASE; DEMOGRAPHY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; LONG TERM CARE; NEUROECTODERM; NONHUMAN; NUCLEAR REPROGRAMMING; PERINATAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REJUVENATION; REVIEW; STEM CELL; T LYMPHOCYTE; TISSUE ENGINEERING; TISSUE REPAIR;

ADULT STEM CELLS; ANIMALS; BIOENGINEERING; EMBRYONIC STEM CELLS; HUMANS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 75949106265     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2009.00096.x     Document Type: Review

References (70)

1. Rossant J. Stem cells and early lineage development. Cell. 2008; 132(4): 527-531.
2. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell. 2008; 132(4): 544-548.
3. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med. 2003; 349(3): 267-274.
4. Klimanskaya I, Rosenthal N, Lanza R. Derive and conquer: Sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov. 2008; 7(2): 131-142.
5. Yamanaka S. Pluripotency and nuclear reprogramming. Phil Trans R Soc B. 2008; 363(1500): 2079-2087.
6. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell. 2008; 132(4): 681-696.
7. Rubin LL. Stem cells and drug discovery: The beginning of a new era? Cell. 2008; 132(4): 549-552.
8. Surani MA, McLaren A. Stem cells: A new route to rejuvenation. Nature. 2006; 443(7109): 284-285.
9. Laird DJ, von Andrian UH, Wagers AJ. Stem cell trafficking in tissue development, growth, and disease. Cell. 2008; 132(4): 612-630.
10. Morrison SJ, Spradling AC. Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life. Cell. 2008; 132(4): 598-611.
11. Kørbling M, Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept? N Engl J Med. 2003; 349(6): 570-582.
12. Knoblich JA. Mechanisms of asymmetric stem cell division. Cell. 2008; 132(4): 583-597.
13. Atala A. Advances in tissue and organ replacement. Curr Stem Cell Res Ther. 2008; 3(1): 21-31.
14. Chien KR. Regenerative medicine and human models of human disease. Nature 2008; 452: 302-305.
15. Silva J, Smith A. Capturing pluripotency. Cell. 2008; 132(4): 532-536.
16. Orkin SH, Zon LI. Hematopoiesis: An evolving paradigm for stem cell biology. Cell. 2008; 132(4): 631-644.
17. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008; 132(4): 645-660.
18. Shizuru JA, Negrin RS, Weissman IL. Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med. 2005; 56: 509-538.
19. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391): 1145-1147.
20. Solter D. From teratocarcinomas to embryonic stem cells and beyond: A history of embryonic stem cell research. Nat Rev Genet. 2006; 7(4): 319-327.
21. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederländer N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007; 204(2): 405-420.
22. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell. 2008; 132(4): 661-680.
23. + biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells. 2008; 26(6): 1464-1474.
24. Wu DC, Boyd AS, Wood KJ. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells. 2008; 26(8): 1939-1950.
25. Matsunaga Y, Fukuma D, Hirata S, Fukushima S, Haruta M, Ikeda T, Negishi I, Nishimura Y, Senju S. Activation of antigen-specific cytotoxic T lymphocytes by beta2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells. J Immunol. 2008; 81(9): 6635-6643.
26. Koch CA, Geraldes P, Platt JL. Immunosuppression by embryonic stem cells. Stem Cells. 2008; 26(1): 89-98.
27. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol. 2005; 23(7): 862-871.
28. Kroon E, Martinson LA, Kadoya K. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008; 26(4): 443-452.
29. Segers V, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008; 451(7181): 937-942.
30. Wu SM, Chien KR, Mummery CL. Origins and fates of cardiovascular progenitor cells. Cell. 2008; 132(4): 537-543.
31. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008; 453: 322-329.
32. Fraidenraich D, Benezra R. Embryonic stem cells prevent developmental cardiac defects in mice. Nat Clin Pract Cardiovasc Med. 2006; 3(Suppl 1): S14-17.
33. Van de Ven C, Collins D, Bradley MB, Morris E, Cairo MS. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp Hematol. 2007; 35(12): 1753-1765.
34. McGuckin CP, Forraz N. Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif. 2008; 41(Suppl 1): 31-40.
35. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007; 25(1): 100-106.
36. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004; 116(5): 639-648.
37. Behfar A, Terzic A. Mesenchymal stem cells: Engineering regeneration. Clin Translation Sci. 2008; 1(1): 34-35.
38. Chamberlain G, Fox J, Ashton B, Middleton J. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25(11): 2739-2749.
39. Phinney DG, Prockop DJ. Mesenchymal stem/multipotent stromal cells: The state of transdiffe-rentiation and modes of tissue repair. Stem Cells. 2007; 25(11): 2896-2902.
40. Caplan AL. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007; 213(2): 341-347.
41. Martinez C, Hofmann TJ, Marino R, Dominici M, Horwitz EM. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: A novel surface marker for the identification of MSCs. Blood. 2007; 109(10): 4245-4248.
42. Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007; 262(5): 509-525.
43. Hochedlinger K, Jaenisch R. Nuclear reprogramming and pluripotency. Nature. 2006; 441(7097): 1061-1067.
44. Armstrong L, Lako M, Dean W, Stojkovic M. Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer. Stem Cells. 2006; 24(4): 805-814.
45. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear repro-gramming. Cell. 2008; 132(4): 567-582.
46. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007; 1(1): 39-49.
47. Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. Generation of human-induced pluripotent stem cells. Nat Protoc. 2008; 3(7): 1180-1186.
48. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5): 877-886.
49. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-676.
50. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 2007; 25(10): 1177-1181.
51. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. Directly reprogrammed fibroblasts show global epi-genetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007; 1(1): 55-70.
52. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151): 313-317.
53. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151): 318-324.
54. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5): 861-872.
55. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008; 451(7175): 141-146.
56. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858): 1917-1920.
57. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008; 321(5893): 1218-1221.
58. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008; 322(5903): 945-949.
59. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008; 26(1): 101-106.
60. Beyhan Z, Iager AE, Cibelli JB. Interspecies nuclear transfer: implications for embryonic stem cell biology. Cell Stem Cell. 2007; 1(5): 502-512.
61. Hall VJ, Stojkovic M. The status of human nuclear transfer. Stem Cell Rev. 2006; 2(4): 301-308.
62. Yang X, Smith SL, Tian XC, Lewin HA, Renard JP, Wakayama T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet. 2007; 39(3): 295-302.
63. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007; 450(7169): 497-502.
64. French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells. 2008; 26(2): 485-493.
65. Nelson TJ, Behfar A, Terzic A. Stem cells: Biologics for regeneration. Clin Pharmacol Ther. 2008; 84(5): 620-623.
66. Nelson TJ, Behfar A, Terzic A. Strategies for therapeutic repair: The "R3" regenerative medicine paradigm. Clin Translation Sci. 2008; 1(2): 168-171.
67. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008; 26(10): 2644-2653.
68. Nelson TJ, Martinez-Fernandez A, Terzic A. KCNJ11 knockout morula reengineered by stem cell diploid aggregation. Phil Trans R Soc B. 2008; 364(1514): 269-276.
69. Waldman SA, Terzic A. Therapeutic targeting: A crucible for individualized medicine. Clin Pharmacol Ther. 2008; 83(5): 651-654.
70. Waldman SA, Terzic MR, Terzic A. Molecular medicine hones therapeutic arts to science. Clin Pharmacol Ther. 2007; 82(4): 343-347.